Incidence of Venous Thromboembolism Based on Caprini Score in Deep Inferior Epigastric Perforator Flap Breast Reconstruction
暂无分享,去创建一个
S. Bernard | R. Djohan | August Culbert | Sarah Bishop | Raffi Gurunian | Rachel Schafer | G. Schwarz | Shannon S. Wu | C. Raymer | Charles Raymer
[1] Shoshana W. Ambani,et al. Standard Fixed Enoxaparin Dosing for Venous Thromboembolism Prophylaxis Leads to Low Peak Anti-Factor Xa Levels in Both Head and Neck and Breast Free Flap Patients. , 2022, Journal of reconstructive microsurgery.
[2] J. Bernstein,et al. Prolonged Venous Thromboembolism Prophylaxis May Not Be Necessary for DIEP Flap Breast Reconstruction: A Tertiary Center's 10-Year Experience. , 2022, Journal of reconstructive microsurgery.
[3] Elizabeth M. Lancaster,et al. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies , 2021, Journal of vascular surgery. Venous and lymphatic disorders.
[4] C. Pannucci,et al. Prevention of Venous Thromboembolism in Microvascular Surgery Patients Using Weight-Based Unfractionated Heparin Infusions , 2021, Journal of Reconstructive Microsurgery.
[5] T. Ballinger,et al. Evaluation of an Extended-duration Chemoprophylaxis Regimen for Venous Thromboembolism after Microsurgical Breast Reconstruction , 2021, Plastic and reconstructive surgery. Global open.
[6] M. Crowley,et al. A novel algorithm to reduce VTE in peri-operative patients on tamoxifen , 2021, Breast.
[7] J. Hijjawi,et al. Clinical course of venous thromboembolism following abdominally based microsurgical breast reconstruction: A case series. , 2021, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[8] A. Chapple,et al. Hospital Length of Stay Is Associated With Increased Likelihood for Venous Thromboembolism After Total Joint Arthroplasty , 2021, Arthroplasty today.
[9] C. Pannucci,et al. Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis , 2020, Annals of surgery.
[10] P. Schauer,et al. Assessment of empiric body mass index-based thromboprophylactic dosing of enoxaparin after bariatric surgery: evidence for dosage adjustment using anti-factor Xa in high-risk patients. , 2020, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.
[11] C. Pannucci,et al. Venous Thromboembolism following Microsurgical Breast Reconstruction: A Longitudinal Analysis of 12,778 Patients , 2020, Plastic and reconstructive surgery.
[12] Scott C. Dolejs,et al. Perioperative Use of Antiestrogen Therapies in Breast Reconstruction , 2020, Annals of plastic surgery.
[13] Na Eun Kim,et al. Standardized Risk Assessment and Risk-Stratified Venous Thromboembolism Prophylaxis for Patients Undergoing Breast Operation. , 2019, Journal of the American College of Surgeons.
[14] C. Pannucci,et al. Breast Reconstruction with Free Abdominal Flaps Is Associated with Persistent Lower Extremity Venous Stasis. , 2019, Plastic and reconstructive surgery.
[15] Dmitry Zavlin,et al. Management of Microsurgical Patients using Intraoperative Unfractionated Heparin and Thromboelastography , 2018, Journal of Reconstructive Microsurgery.
[16] Bernard T. Lee,et al. Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction? , 2018, Plastic and reconstructive surgery.
[17] C. Pannucci,et al. Adequacy of Fixed-Dose Heparin Infusions for Venous Thromboembolism Prevention after Microsurgical Procedures , 2018, Journal of Reconstructive Microsurgery.
[18] A. Modarressi,et al. Venous thromboembolism events after breast reconstructions with DIEP free flaps in 192 consecutive case. , 2017, Annales de chirurgie plastique et esthetique.
[19] E. Garfein,et al. Risk Factors for Postoperative Venous Thromboembolic Complications after Microsurgical Breast Reconstruction , 2017, Journal of Reconstructive Microsurgery.
[20] R. Bosc,et al. Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[21] R. Dorfman,et al. Surgical Duration Impacts Venous Thromboembolism Risk in Microsurgical Breast Reconstruction , 2017, Journal of Reconstructive Microsurgery.
[22] P. Harris,et al. Audit of venous thromboembolism in DIEP free flap breast reconstruction. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[23] B. Brooke,et al. Individualized Venous Thromboembolism Risk Stratification Using the 2005 Caprini Score to Identify the Benefits and Harms of Chemoprophylaxis in Surgical Patients: A Meta-analysis , 2017, Annals of surgery.
[24] Allen Kachalia,et al. Implementation of a Comprehensive Post-Discharge Venous Thromboembolism Prophylaxis Program for Abdominal and Pelvic Surgery Patients. , 2016, Journal of the American College of Surgeons.
[25] G. Evans,et al. The Effects of Perioperative Tamoxifen Therapy on Microvascular Flap Complications in Transverse Rectus Abdominis Myocutaneous/Deep Inferior Epigastric Perforator Flap Breast Reconstruction , 2016, Annals of plastic surgery.
[26] Michael G. Tecce,et al. Increased Lower Extremity Venous Stasis May Contribute to Deep Venous Thrombosis Formation after Microsurgical Breast Reconstruction—An Ultrasonographic Study , 2016, Journal of Reconstructive Microsurgery.
[27] M. Höistad,et al. Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials. , 2016, Breast.
[28] S. Ariyan,et al. Benefits and Risks of Prophylaxis for Deep Venous Thrombosis and Pulmonary Embolus in Plastic Surgery: A Systematic Review and Meta-Analysis of Controlled Trials and Consensus Conference , 2016, Plastic and reconstructive surgery.
[29] M. Hawn,et al. Association Between Inpatient Surveillance and Venous Thromboembolism Rates After Hospital Discharge. , 2015, JAMA surgery.
[30] Suhail K. Kanchwala,et al. Tamoxifen (Selective Estrogen-Receptor Modulators) and Aromatase Inhibitors as Potential Perioperative Thrombotic Risk Factors in Free Flap Breast Reconstruction , 2015, Plastic and reconstructive surgery.
[31] D. Mahvi,et al. Surgical duration and risk of venous thromboembolism. , 2015, JAMA surgery.
[32] N. Adhikari,et al. Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review , 2014, Critical Care.
[33] J. Fischer,et al. Venous Thromboembolism Risk in Mastectomy and Immediate Breast Reconstruction: Analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program Data Sets , 2014, Plastic and reconstructive surgery.
[34] G. Evans,et al. Predictive Risk Factors of Venous Thromboembolism in Autologous Breast Reconstruction Surgery , 2014, Annals of plastic surgery.
[35] R. Timman,et al. Pulmonary Embolism after Abdominal Flap Breast Reconstruction: Prediction and Prevention , 2013, Plastic and reconstructive surgery.
[36] M. Fang,et al. Assessing bleeding risk in patients taking anticoagulants , 2013, Journal of Thrombosis and Thrombolysis.
[37] K. Eley,et al. Functional fibrinogen to platelet ratio using thromboelastography as a predictive parameter for thrombotic complications following free tissue transfer surgery: A preliminary study , 2012, Microsurgery.
[38] A. Khan,et al. Breast reconstruction with deep inferior epigastric perforator flaps , 2012, Annals of the Royal College of Surgeons of England.
[39] D. Smith. Venous Thromboembolism following Microsurgical Breast Reconstruction: An Objective Analysis in 225 Consecutive Patients Using Low-Molecular-Weight Heparin Prophylaxis , 2012 .
[40] J. Rubin,et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. , 2011, Journal of the American College of Surgeons.
[41] Bernard T. Lee,et al. Patient Satisfaction in Postmastectomy Breast Reconstruction: A Comparative Evaluation of DIEP, TRAM, Latissimus Flap, and Implant Techniques , 2010, Plastic and reconstructive surgery.
[42] C. Pannucci,et al. Venous Thromboembolic Disease in Autogenous Breast Reconstruction , 2009, Annals of plastic surgery.
[43] M. Huo,et al. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review. , 2009, Clinical therapeutics.
[44] A. Madan,et al. Anti-Xa Levels in Bariatric Surgery Patients Receiving Prophylactic Enoxaparin , 2008, Obesity surgery.
[45] C. Kirwan,et al. Prevention of venous thromboembolism in surgical patients with breast cancer , 2007, The British journal of surgery.
[46] H. Chew,et al. Incidence of venous thromboembolism and the impact on survival in breast cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] F. Parazzini,et al. A Clinical Outcome-Based Prospective Study on Venous Thromboembolism After Cancer Surgery: The @RISTOS Project , 2006, Annals of surgery.
[48] L. Ford,et al. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.
[49] J. Caprini. Thrombosis risk assessment as a guide to quality patient care. , 2005, Disease-a-month : DM.
[50] P. Blondeel,et al. Bilateral Autogenous Breast Reconstruction Using Perforator Free Flaps: A Single Center’s Experience , 2004, Plastic and reconstructive surgery.
[51] R. Allen,et al. Bilateral Breast Reconstruction with the Deep Inferior Epigastric Perforator (DIEP) Flap: An Experience with 280 Flaps , 2004, Annals of plastic surgery.
[52] C. Kearon. Duration of venous thromboembolism prophylaxis after surgery. , 2003, Chest.
[53] M Baum,et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial , 2002, The Lancet.
[54] J. Cuzick,et al. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial , 2002, The Lancet.
[55] J. Mackay. IBIS investigators. First results from the International Breast Cancer Intervention Study (IBIS-1) - a randomised prevention trial , 2002 .
[56] F. Alexander,et al. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial , 1995, BMJ.